HER2 expression as a potential marker for response to therapy targeted to the EGFR

類似資料

• Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers
  著者:: Khelwatty, Said A, 等
  出版事項: (2015)
• EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy
  著者:: Evans, A H, 等
  出版事項: (2010)
• Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy
  著者:: Jimeno, A, 等
  出版事項: (2007)
• Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies
  著者:: Laux, I, 等
  出版事項: (2006)
• Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma
  著者:: Kawaguchi, Y, 等
  出版事項: (2007)